Stay updated with breaking news from Matthew Segall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Optibrium, a developer of software and AI solutions for drug discovery, has acquired BioPharmics in a view to expand its 3D drug design and modelling offering.
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC.
Instead of continuing to rely on trial-and-error testing, pharmaceutical scientists are increasingly turning to computer software to create better treatments.
New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team.
Research shows how novel predictive models develop drug design and reduce toxicity - News - PharmaTimes